Clifford Chance has a formidable team in Spain, most notably in contentious patent work, where partner Miquel Montañá is recognised as one of the strongest individuals for pharmaceutical matters. It had an active year in trade mark work and moves up a Tier.
Through 2010 the firm represented clients including Novartis, which it advised in a number of high-profile cases, Pfizer, Philip Morris International and Reckitt Benckiser. In a recent case the firm acted for Bayer Cropscience and DuPont De Nemours in a criminal dispute protecting their patent rights and hitting out at the illegal market for phytosanitary products. The firm also successfully represented DuPont in patent validity and infringement proceedings against Safety Hi-Tech in Barcelona.
The firm advised Eli Lilly in patent infringement proceedings against companies that have obtained marketing authorisation for olanzapine generics and, on the trade mark side, acted for Honda in various court proceedings involving infringement of its Community trade marks by way of parallel imports. The latter case resulted in damages and injunctions against three companies.